Your browser doesn't support javascript.
loading
Combining T-cell-based immunotherapy with venetoclax elicits synergistic cytotoxicity to B-cell lines in vitro.
Murakami, Satsuki; Suzuki, Susumu; Hanamura, Ichiro; Yoshikawa, Kazuhiro; Ueda, Ryuzo; Seto, Masao; Takami, Akiyoshi.
Afiliação
  • Murakami S; Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
  • Suzuki S; Research Creation Support Center, Aichi Medical University, Nagakute, Aichi, Japan.
  • Hanamura I; Department of Tumor Immunology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
  • Yoshikawa K; Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
  • Ueda R; Research Creation Support Center, Aichi Medical University, Nagakute, Aichi, Japan.
  • Seto M; Department of Tumor Immunology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
  • Takami A; Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
Hematol Oncol ; 38(5): 705-714, 2020 Dec.
Article em En | MEDLINE | ID: mdl-32822067

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonamidas / Linfócitos B / Linfócitos T / Compostos Bicíclicos Heterocíclicos com Pontes / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Hematol Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonamidas / Linfócitos B / Linfócitos T / Compostos Bicíclicos Heterocíclicos com Pontes / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Hematol Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão